You are here

patents

Amgen's Enbrel Patents to Be Upheld Through 2029

Amgen's Enbrel Patents to Be Upheld Through 2029

Motley Fool

rheumatoid arthritis

Flag link:

Mylan, seeking to market Victoza generic, convinces panel to start up patent review

Mylan, seeking to market Victoza generic, convinces panel to start up patent review

Fierce Pharma

Flag link:

Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch

Mylan, looking to capitalize on Biogen's Tecfidera patent loss, faces fork in the road on generic launch

Fierce Pharma

multiple sclerosis

Flag link:

Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan

Judge wipes out Biogen's Tecfidera patent protections in suit against Mylan

Fierce Pharma

multiple sclerosis

Flag link:

FDA addresses ANDA conversion to tentative approval for patent infringement

FDA addresses ANDA conversion to tentative approval for patent infringement

RAPS.org

Patent Infringement

Flag link:

AbbVie's Humira defense may keep prices high, but it's still legal, judge rules

AbbVie's Humira defense may keep prices high, but it's still legal, judge rules

Fierce Pharma

Flag link:

The WHO launched a voluntary Covid-19 product pool. What happens next?

The WHO launched a voluntary Covid-19 product pool. What happens next?

Stat

drug development

Flag link:

FDA looks to overhaul Orange Book, seeks input on patent listings

FDA looks to overhaul Orange Book, seeks input on patent listings

RAPS.org

Flag link:

Pharma leaders shoot down WHO voluntary pool for patent rights on Covid-19 products

Pharma leaders shoot down WHO voluntary pool for patent rights on Covid-19 products

Stat

Flag link:

The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit

The U.S. government contributed research to a Gilead remdesivir patent — but didn’t get credit

Stat

Gilead Sciences

federal government

Flag link:

Gilead charges CDC with contract breach on HIV research

Gilead charges CDC with contract breach on HIV research

Seeking Alpha

Gilead Sciences

Flag link:

Biogen Sues Company Over Allegedly Selling Knockoff Alzheimer's Treatment

Biogen Sues Company Over Allegedly Selling Knockoff Alzheimer's Treatment

BioSpace

Alzheimer's disease

Creative Biolabs

Flag link:

Calling Gilead's CAR-T infringement 'willful,' judge enhances BMS' award to $1.2B

Calling Gilead's CAR-T infringement 'willful,' judge enhances BMS' award to $1.2B

Fierce Pharma

Gilead Sciences

Bristol-Myers Squibb

Flag link:

Are Amarin's Blockbuster Dreams Over?

Are Amarin's Blockbuster Dreams Over?

Motley Fool

Flag link:

Some pharmas acting like “toilet roll profiteers” on COVID-19, says clinician

Some pharmas acting like “toilet roll profiteers” on COVID-19, says clinician

Pharmaforum

artificial intelligence

Flag link:

Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb

Motion denied: Gilead still on the hook for $1.5B in damages over CAR-T patent dispute with Bristol Myers Squibb

Endpoints

Gilead Sciences

Bristol-Meyers Squibb

Juno Therapeutics

Flag link:

Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss

Disaster at Amarin: Stock plummets 70% after Vascepa patent challenge loss

Fierce Pharma

Flag link:

AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report

AbbVie gives up patent rights to HIV med Kaletra amid COVID-19 tests: report

Fierce Pharma

Flag link:

Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court

Gilead loses again in PrEP patent fight with HHS, sending dispute to federal court

Fierce Pharma

Gilead Sciences

Flag link:

Court Finds Sanofi Improperly Listed Insulin Device Patent in FDA’s Orange Book

Court Finds Sanofi Improperly Listed Insulin Device Patent in FDA’s Orange Book

RAPS.org

Flag link:

Pages